Live Updates: COVID-19 Cases
  • World 13,081,755
    World
    Confirmed: 13,081,755
    Active: 4,884,689
    Recovered: 7,624,522
    Death: 572,544
  • USA 3,414,582
    USA
    Confirmed: 3,414,582
    Active: 1,759,217
    Recovered: 1,517,570
    Death: 137,795
  • Brazil 1,866,176
    Brazil
    Confirmed: 1,866,176
    Active: 580,513
    Recovered: 1,213,512
    Death: 72,151
  • India 888,944
    India
    Confirmed: 888,944
    Active: 305,304
    Recovered: 560,307
    Death: 23,333
  • Russia 733,699
    Russia
    Confirmed: 733,699
    Active: 218,239
    Recovered: 504,021
    Death: 11,439
  • Peru 326,326
    Peru
    Confirmed: 326,326
    Active: 97,345
    Recovered: 217,111
    Death: 11,870
  • Chile 315,041
    Chile
    Confirmed: 315,041
    Active: 24,160
    Recovered: 283,902
    Death: 6,979
  • Spain 300,988
    Spain
    Confirmed: 300,988
    Active: 272,585
    Recovered: ?
    Death: 28,403
  • Mexico 299,750
    Mexico
    Confirmed: 299,750
    Active: 79,980
    Recovered: 184,764
    Death: 35,006
  • UK 289,603
    UK
    Confirmed: 289,603
    Active: 244,784
    Recovered: ?
    Death: 44,819
  • South Africa 276,242
    South Africa
    Confirmed: 276,242
    Active: 137,289
    Recovered: 134,874
    Death: 4,079
  • Iran 259,652
    Iran
    Confirmed: 259,652
    Active: 24,081
    Recovered: 222,539
    Death: 13,032
  • Pakistan 251,625
    Pakistan
    Confirmed: 251,625
    Active: 84,442
    Recovered: 161,917
    Death: 5,266
  • Italy 243,061
    Italy
    Confirmed: 243,061
    Active: 13,179
    Recovered: 194,928
    Death: 34,954
  • Saudi Arabia 235,111
    Saudi Arabia
    Confirmed: 235,111
    Active: 63,026
    Recovered: 169,842
    Death: 2,243
  • Turkey 212,993
    Turkey
    Confirmed: 212,993
    Active: 13,115
    Recovered: 194,515
    Death: 5,363
  • Germany 200,047
    Germany
    Confirmed: 200,047
    Active: 5,812
    Recovered: 185,100
    Death: 9,135
  • Bangladesh 186,894
    Bangladesh
    Confirmed: 186,894
    Active: 86,186
    Recovered: 98,317
    Death: 2,391
  • France 170,752
    France
    Confirmed: 170,752
    Active: 62,360
    Recovered: 78,388
    Death: 30,004
  • Canada 107,590
    Canada
    Confirmed: 107,590
    Active: 27,340
    Recovered: 71,467
    Death: 8,783
  • China 83,602
    China
    Confirmed: 83,602
    Active: 320
    Recovered: 78,648
    Death: 4,634
  • Netherlands 51,093
    Netherlands
    Confirmed: 51,093
    Active: 44,956
    Recovered: ?
    Death: 6,137
  • S. Korea 13,479
    S. Korea
    Confirmed: 13,479
    Active: 986
    Recovered: 12,204
    Death: 289
  • Australia 9,980
    Australia
    Confirmed: 9,980
    Active: 2,104
    Recovered: 7,768
    Death: 108
  • New Zealand 1,544
    New Zealand
    Confirmed: 1,544
    Active: 25
    Recovered: 1,497
    Death: 22

Hydroxychloroquine no wonder drug for treating COVID-19, can be fatal: Experts

Author at TechGenyz Health
Hydroxychloroquine no wonder drug for COVID-19 patients
Hydroxychloroquine

As countries around the world explore the potential of hydroxychloroquine drug to treat COVID-19 patients, several experts have sounded a note of warning to say it is not a wonder drug and may even be fatal in some cases.

While frantic efforts are underway to develop a vaccine and doctors all over try and control the spread of the disease for which there is yet no cure, hydroxychloroquine, or HCQ, has emerged as a prime focus area of treatment.

This reliance on HCQ must immediately stop, the experts say, adding their voices to the growing debate to stress that there is no scientific evidence to prove that it is beneficial in treating COVID-19.

It is only on anecdotal evidence that doctors are using HCQ along with other antiviral medication (used in HIV and other viral infections) as empiric therapy to treat COVID-19 patients as there is no definite treatment available yet, said M C Misra, former director of the All India Institute of Medical Sciences (AIIMS) in Delhi and one of India's top surgeons.

However, there have been reports of some patients developing cardiac arrhythmias due to hydroxychloroquine which can cause sudden cardiac death, Misra told PTI.

Yudhyavir Singh, a core member of AIIMS' COVID-19 team deployed at the hospital's trauma centre, agreed.

Globally, some deaths have been reported due to the administration of HCQ alone and along with azithromycin as well. HCQ blocks the potassium channel and potentially prolongs the QTc (heartbeat) with consequences of sudden cardiac arrest death and various arrhythmias. This has also been documented in prominent studies, he explained.

The assistant professor of anaesthesia at AIIMS said there are contradictory reports on HCQ usage for treating COVID-19.

As the pandemic spreads and the urgency for effective treatment of COVID-19 mounts, several countries, including the US, have started relying heavily on HCQ, majorly used in the treatment of malaria and rheumatoid-arthritis.

India has become the biggest supplier of the drug and has fulfilled large orders from countries such as the US, UAE and UK.

With US President Donald Trump touting the anti-malaria drug as a definite cure for COVID-19, his administration has stockpiled millions of doses of HCQ despite the US Food and Drug Administration (FDA) issuing a safety communication regarding the known side effects of the drug.

The FDA said HCQ has been given Emergency Use Authorisation' for the treatment of patients who have tested positive for coronavirus but its side effects include serious and potentially life-threatening heart rhythm problems.

In India too, HCQ is being used by many hospitals to treat COVID-19 patients though there is no scientific proof of its benefit for the disease.

We are using HCQ among other drugs but ignoring its extreme hazardous side effects, Misra said.

In the first week of April, when coronavirus cases in India started to surge, a doctor in Assam who was put on a high dose of HCQ after he showed COVID-19 symptoms died of a cardiac arrest, he said.

Citing research from France in which one-half of COVID-19 patients was administered hydroxychloroquine drug while the other half was not, Misra said the recovery and outcomes of the two groups were the same.

Another study submitted in The New England Journal of Medicine on April 4, 2020, concluded that HCQ administration to the hospitalized SARS-CoV- 2 positive population was associated with an increased need for escalation of respiratory support, he said, adding that hydroxychloroquine was not a wonder drug.

COVID-19, which broke out first in China's Hubei province, has caused havoc across the world, claiming the lives of more than 2.6 lakh people and infected over 37 lakh.

Ashraf Ganie, professor of endocrinology at Srinagar's Sher-I-Kashmir Institute of Medical Sciences, described as brazen the manner in which HCQ was being projected as a cure for treating coronavirus.

HCQ can have serious cardiac side effects and cannot be used without prior evaluation, Ganie told PTI.

"There is no quality scientific evidence available, which can prove the efficacy of the drug in prevention or cure of COVID 19, added D K Mangal, director of the Centre for Health Systems and Policy Research in Jaipur's IIHMR University. It should be used with precautions for patients with severe heart disease and require continuous monitoring of the QT interval. HCQ is known for its cadio-toxicity. Hence it should be used in health care settings only, he told PTI.

Rajesh Kumar, a doctor of Internal Medicine at Gurgaon's Paras Hospital, said HCQ can also cause hypoglycemia in diabetes patients.

We Are Hiring

Subscribe